Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023

SELL
$62.39 - $113.8 $116 Million - $212 Million
-1,863,759 Reduced 92.0%
162,062 $18.4 Million
Q3 2022

Nov 09, 2022

BUY
$58.92 - $84.67 $22.6 Million - $32.5 Million
384,278 Added 23.41%
2,025,821 $125 Million
Q2 2022

Aug 10, 2022

SELL
$79.4 - $116.36 $16.9 Million - $24.7 Million
-212,320 Reduced 11.45%
1,641,543 $131 Million
Q1 2022

May 11, 2022

SELL
$86.42 - $109.81 $41.3 Million - $52.5 Million
-477,823 Reduced 20.49%
1,853,863 $195 Million
Q4 2021

Feb 14, 2022

SELL
$98.56 - $119.91 $77.4 Million - $94.2 Million
-785,682 Reduced 25.2%
2,331,686 $251 Million
Q3 2021

Nov 10, 2021

SELL
$91.91 - $110.37 $117 Million - $141 Million
-1,276,319 Reduced 29.05%
3,117,368 $341 Million
Q2 2021

Aug 12, 2021

BUY
$86.24 - $95.92 $21.1 Million - $23.5 Million
244,492 Added 5.89%
4,393,687 $411 Million
Q1 2021

May 13, 2021

SELL
$71.83 - $95.48 $79.4 Million - $105 Million
-1,104,803 Reduced 21.03%
4,149,195 $382 Million
Q4 2020

Feb 09, 2021

SELL
$67.0 - $84.39 $40.1 Million - $50.6 Million
-599,224 Reduced 10.24%
5,253,998 $384 Million
Q3 2020

Nov 06, 2020

SELL
$55.23 - $79.93 $97.6 Million - $141 Million
-1,766,356 Reduced 23.18%
5,853,222 $455 Million
Q2 2020

Aug 12, 2020

SELL
$30.2 - $56.98 $21.2 Million - $39.9 Million
-700,367 Reduced 8.42%
7,619,578 $423 Million
Q1 2020

May 08, 2020

SELL
$24.87 - $38.56 $13.3 Million - $20.7 Million
-535,545 Reduced 6.05%
8,319,945 $246 Million
Q4 2019

Feb 12, 2020

BUY
$25.43 - $36.67 $13.1 Million - $18.9 Million
515,049 Added 6.18%
8,855,490 $321 Million
Q3 2019

Nov 12, 2019

BUY
$23.0 - $27.97 $31.8 Million - $38.7 Million
1,382,138 Added 19.86%
8,340,441 $227 Million
Q2 2019

Aug 09, 2019

BUY
$22.81 - $28.48 $159 Million - $198 Million
6,958,303 New
6,958,303 $167 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track William Blair Investment Management, LLC Portfolio

Follow William Blair Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of William Blair Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on William Blair Investment Management, LLC with notifications on news.